Evidence map›Paper›PMID 35867351›Full record

ArticleAnnals of neurology2022

Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART.

Catherine R Cochrane, Thomas A Angelovich, Sarah J Byrnes, Emily Waring, Aleks C Guanizo, Gemma S Trollope, Jingling Zhou, Judith Vue, Lachlan Senior, Emma Wanicek and 9 more

Abstract read
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Catherine R Cochrane *Emerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0001-9683-8905
Thomas A Angelovich *Emerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0003-2069-0451
Sarah J ByrnesEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Emily WaringEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Aleks C GuanizoEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Gemma S TrollopeEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Jingling ZhouEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Judith VueEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Lachlan SeniorEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Emma WanicekEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Janna Jamal EddineEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Matthew J GartnerDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.ORCID 0000-0003-4953-9501
Trisha A JenkinsEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0003-0137-6643
Paul R GorryEmerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0001-5407-7124
Bruce J BrewPeter Duncan Neurosciences Unit, Departments of Neurology and Immunology St Vincent's Hospital, Sydney, University of New South Wales and University of Notre Dame, Sydney, New South Wales, Australia.ORCID 0000-0003-0622-1392
Sharon R LewinDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.ORCID 0000-0002-0330-8241
Jacob D EstesVaccine and Gene Therapy Institute, Oregon National Primate Research Centre, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0002-9652-6394
Michael Roche *Emerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0001-8819-0096
Melissa J Churchill *Emerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0001-5510-7954

Funding

The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
Characterization of the intact and defective HIV reservoirs in myeloid cells in the brainR21DA055489 · NIDA · ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY · PI ANGELOVICH, THOMAS A, CHURCHILL, MELISSA · 2021 to 2022
$272k
NIDA NIH HHS R21 DA055489NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

objectiveHuman immunodeficiency virus (HIV) persistence in blood and tissue reservoirs, including the brain, is a major barrier to HIV cure and possible cause of comorbid disease. However, the size and replication competent nature of the central nervous system (CNS) reservoir is unclear. Here, we used the intact proviral DNA assay (IPDA) to provide the first quantitative assessment of the intact and defective HIV reservoir in the brain of people with HIV (PWH).

methodsTotal, intact, and defective HIV proviruses were measured in autopsy frontal lobe tissue from viremic (n = 18) or virologically suppressed (n = 12) PWH. Total or intact/defective proviruses were measured by detection of HIV pol or the IPDA, respectively, through use of droplet digital polymerase chain reaction (ddPCR). HIV-seronegative individuals were included as controls (n = 6).

resultsTotal HIV DNA was present at similar levels in brain tissues from untreated viremic and antiretroviral (ART)-suppressed individuals (median = 22.3 vs 26.2 HIV pol copies/10

interpretationOur results demonstrate the first evidence for an intact, potentially replication competent HIV reservoir in the CNS of virally suppressed PWH. ANN NEUROL 2022;92:532-544.

Indexed as

HIV InfectionsProvirusesAnti-Retroviral AgentsBrainCD4-Positive T-LymphocytesDNA, ViralHumansViral LoadAnti-Retroviral AgentsDNA, Viral

Identifiers

PMID35867351
PMCPMC9489665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.